Skip to main content
Caplight Logo









BrosMed Medical

BrosMed Medical

Private
DongguanHealthcare & Life Scienceshttps://www.brosmed.com/

Last Round

Series C

Jul 27, 2020

Company Overview

BrosMed Medical is a medical device company that specializes in the research, development, production, and global sales of high-performance intravascular interventional medical devices and accessories.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

interventional medical devicesballoon cathetermicrocatheterPTCApercutaneous transluminal coronary angioplastyPTApercutaneous transluminal angioplastyvascular interventioncardiovascular devicesminimally invasive surgeryOEM medical devicesvascular stenosis treatmentinterventional cardiologymedical consumablescatheter manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrosMed Medical Comparables

Compare BrosMed Medical with similar companies based on industry and business-model similarity.

BrosMed Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kossel Medtech (Suzhou) Co., Ltd.
89%
SIS Medical AG
87%
DK Medical Technology (Suzhou) Co., Ltd.
87%

BrosMed Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 27, 2020
Series AJan 1, 2014

Key People

Founding team and executive leadership

Scott J Addonizio

Chief Operating Officer

Executive Team

BrosMed Medical Investors

Notable investors and investment history

BrosMed Medical investors
InvestorRounds
Cathay CapitalSeries C
Northern Light Venture CapitalSeries C
Cowin CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    Grew 17% QoQ, from 70 to 82 employees.

  • Jan 2, 2026

    Monthly visitors grew 125% MoM, reaching 2K.

BrosMed Medical Filings

Explore SEC and related filing metadata, where available.

BrosMed Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BrosMed Medical's valuation, stock price, and market status.

Is BrosMed Medical a public or private company?

BrosMed Medical is a private company.

What is the current stock price of BrosMed Medical?

BrosMed Medical is a private company with no public stock price. No recent secondary market data is available.

How much is BrosMed Medical worth (valuation)?

Valuation information for BrosMed Medical is not publicly available.

Can I buy BrosMed Medical stock?

BrosMed Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BrosMed Medical's last funding round?

BrosMed Medical's most recent funding round was Series C on July 27, 2020.

Who are the main investors in BrosMed Medical?

Key investors in BrosMed Medical include Cathay Capital, Northern Light Venture Capital, Cowin Capital.

Will BrosMed Medical IPO soon?

No public IPO plans have been announced for BrosMed Medical.

How can I track BrosMed Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BrosMed Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDongguan
Employee Range96
Year Founded2012
Last FundingJul 27, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?